{
    "nctId": "NCT06038110",
    "briefTitle": "Use of Axillary Ultrasound to Guide Breast Cancer Management in the Genomic Assay Era",
    "officialTitle": "Use of Axillary Ultrasound to Guide Breast Cancer Management in the Genomic Assay Era: A Retrospective Cohort Study",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Axillary Ultrasound",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "the number of abnormal nodes on ultrasound",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* breast cancer patients with T1-3, HR-positive and HER2-negative disease.\n* aged\u2265 50 years old\n* had axillary ultrasound prior to operation\n* axillary lymph node dissection\n\nExclusion Criteria:\n\n* Patients with neoadjuvant chemotherapy\n* bilateral cancers",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}